23 Dec 2016
Published in News

US: SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges

The Securities and Exchange Commission and the Department of Justice jointly fined Teva Pharmaceutical Industries Limited TEVA, +1.48% the largest generic drug manufacturer in the world, $519 million on Thursday to settle parallel civil and criminal charges that it allegedly violated the Foreign Corrupt Practices Act when it paid bribes to foreign government officials in Russia, Ukraine, and Mexico between 2002 and 2012.